Among other findings, we demonstrated that THSD7A overexpression is significantly associated with unfavorable prognostic parameters in prostate cancer, including the tumor stage, Gleason grade and lymph node metastasis as well as PSA recurrence. This evidence concerns the gene THSD7A and neoplasm.